Cargando…

Chemotherapy and terminal skeletal muscle differentiation in WT1‐mutant Wilms tumors

Wilms tumors (WT) with WT1 mutations do not respond well to preoperative chemotherapy by volume reduction, suggesting resistance to chemotherapy. The histologic pattern of this tumor subtype indicates an intrinsic mesenchymal differentiation potential. Currently, it is unknown whether cytotoxic trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Royer‐Pokora, Brigitte, Beier, Manfred, Brandt, Artur, Duhme, Constanze, Busch, Maike, de Torres, Carmen, Royer, Hans‐Dieter, Mora, Jaume
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911586/ https://www.ncbi.nlm.nih.gov/pubmed/29542868 http://dx.doi.org/10.1002/cam4.1379

Ejemplares similares

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations
por: Royer-Pokora, Brigitte, et al.
Publicado: (2020)

Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation
por: Busch, Maike, et al.
Publicado: (2014)

Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin
por: Royer-Pokora, Brigitte, et al.
Publicado: (2023)

Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15
por: Brandt, Artur, et al.
Publicado: (2016)

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2
por: Rapley, E A, et al.
Publicado: (2000)

The Wilms’ tumor (WT1) gene: Methods and protocols
por: Agrawal, Suraksha
Publicado: (2018)

Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
por: Berry, Rachel L., et al.
Publicado: (2015)

Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
por: Coosemans, A.
Publicado: (2011)

Wilms Tumor-1 (WT1) rs16754 Polymorphism
por: Sookaromdee, Pathum, et al.
Publicado: (2019)

Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
por: Wagner, Nicole, et al.
Publicado: (2021)

Every Beat You Take—The Wilms′ Tumor Suppressor WT1 and the Heart
por: Wagner, Nicole, et al.
Publicado: (2021)

A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
por: Kaneko, Y, et al.
Publicado: (2015)

TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
por: Makki, Mohammad Shahidul, et al.
Publicado: (2008)

Studies of Wilms’ Tumor (WT1) Gene Expression in Adult Acute Leukemias in Singapore
por: Lim, Che Kang, et al.
Publicado: (2007)

Nephron, Wilms’ tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice
por: Kato, Takashi, et al.
Publicado: (2017)

The Wilms tumor protein Wt1 contributes to female fertility by regulating oviductal proteostasis
por: Nathan, Abinaya, et al.
Publicado: (2017)

Assessment of somatic mutations in urine and plasma of Wilms tumor patients
por: Miguez, Ana Carolina Kerekes, et al.
Publicado: (2020)

HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU
por: Sun, Jun, et al.
Publicado: (2021)

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo
por: Benteyn, Daphné, et al.
Publicado: (2013)

Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
por: Goyal, Surbhi, et al.
Publicado: (2016)

TERT Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
por: Jablonowski, Carolyn M., et al.
Publicado: (2022)

Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant
por: Falcone, Maria Pia, et al.
Publicado: (2021)

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
por: Busse, Antonia, et al.
Publicado: (2010)

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor
por: Dallosso, Anthony R., et al.
Publicado: (2009)

The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi
por: Hartkamp, Jörg, et al.
Publicado: (2010)

The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
por: Brett, Adina, et al.
Publicado: (2013)

Wilms’ tumor 1 (WT1) as a prognosis factor in gynecological cancers: A meta-analysis
por: Lu, Jingjing, et al.
Publicado: (2018)

Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
por: Oji, Yusuke, et al.
Publicado: (1999)

Wilms Tumor-1 (WT1) rs16754 Polymorphism and Clinical Outcome in Acute Myeloid Leukemia
por: Ramzi, Mani, et al.
Publicado: (2019)

The Wilms Tumor Gene wt1a Contributes to Blood-Cerebrospinal Fluid Barrier Function in Zebrafish
por: Hopfenmüller, Vera L., et al.
Publicado: (2022)

Corrigendum: Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan
por: Lu, Meng-Yao, et al.
Publicado: (2022)

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
por: Monzavi, Seyed Mostafa, et al.
Publicado: (2023)

Targeting the ‘garbage-bin’ to fight cancer: HDAC6 inhibitor WT161 has an anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU
por: Sergi, Consolato M.
Publicado: (2021)

Correction: Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor
por: Dallosso, Anthony R., et al.
Publicado: (2009)

Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
por: Cowell, J. K., et al.
Publicado: (1993)

PPARβ activation inhibits melanoma cell proliferation involving repression of the Wilms’ tumour suppressor WT1
por: Michiels, Jean-François, et al.
Publicado: (2010)

Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms’ Tumor Gene, WT1
por: Scholz, Holger, et al.
Publicado: (2011)

Deletion of WT1 and WIT1 Genes and Loss of Heterozygosity on Chromosome 11p in Wilms Tumors in Japan
por: Kaneko, Yasuhiko, et al.
Publicado: (1993)

Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort
por: Stoltze, Ulrik Kristoffer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a7v1eo79s0686ohjb3l48b7eal